Cancer Page 605

More in Cancer

  1. Pituitary Neuroendocrine Tumor: Symptoms & Treatment

    Explore how pituitary tumors disrupt body systems through hormonal effects or physical pressure, and understand the modern approaches to diagnosis and care.

    By Darlene Watson
  2. Esophageal Cancer Weight Loss: Causes and Management

    Understand the complex reasons for weight loss in esophageal cancer and how proactive nutritional management supports treatment tolerance and well-being.

    By Andrea Galbraith
  3. Inflammation of a Small Cell: Explaining the Cancer Link

    Discover how the body’s inflammatory response contributes to small cell carcinoma and is then used by the cancer itself to help it grow, spread, and survive.

    By Elizabeth C. Owens
  4. What Are Secondary Malignancies After Cancer Treatment?

    Understand the distinction between a cancer recurrence and a secondary malignancy—a new, unrelated cancer that can arise as a late effect of treatment.

    By Donna Tarasenko
  5. What Is GD2 and How Is It Targeted in Cancer?

    Learn how the GD2 molecule’s presence on cancer cells makes it a target for immunotherapy, and how its location on nerve cells creates unique clinical challenges.

    By Angela Sorensen
  6. Is HPV Bad? What to Know About Warts and Cancer Risks

    Most HPV infections are harmless. Learn the difference between viral strains and how proactive screening and prevention can effectively manage long-term health risks.

    By Grace Torres
  7. MDA-MB-231 Triple Negative: What Is This Cell Line?

    Learn about the MDA-MB-231 cell line, a vital but imperfect model that has shaped our understanding of aggressive triple-negative breast cancer.

    By Orlando Serrano
  8. HIV and the Increased Risk of Skin Cancer

    Understand the link between HIV-related immune suppression and a higher risk for skin malignancies, and the importance of integrated dermatological care.

    By Emily Gentile
  9. Can Immunotherapy Cure Metastatic Cancer?

    For a subset of patients, immunotherapy offers lasting remission from metastatic cancer, fundamentally changing the possibilities and the definition of a cure.

    By Estela Gallegos
  10. EGFR Amplification: What It Is and Why It Matters in Cancer

    Learn how an excess of the EGFR gene drives uncontrolled cell growth in some cancers and how this knowledge guides precise, targeted therapeutic approaches.

    By Nada Farah
  11. AML Mutations: How They Affect Prognosis and Treatment

    In AML, specific genetic mutations are crucial for determining prognosis and selecting the most effective, personalized treatment options.

    By Justin Hernandez
  12. What Is the EGFR Exon 21 Mutation in Lung Cancer?

    Understanding the EGFR Exon 21 mutation provides a roadmap for personalized lung cancer care, guiding therapies that target the cancer’s specific driver.

    By Nada Farah
  13. What Is the Risk of Secondary Cancer After Thyroid Cancer?

    Understand the long-term health implications of treatment, including the nuanced risk of a new cancer, to ensure proactive and informed survivorship care.

    By Anna Mayer
  14. What Is a Tankyrase Inhibitor for Cancer Treatment?

    Explore tankyrase inhibitors, an investigational class of targeted therapy designed to interrupt the cellular signaling that drives cancer growth.

    By Linnea Aziz